ClinicalTrials.gov
public full text
Public Domain
Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
OBJECTIVES: I. Determine the response rate and 1-year event-free survival of patients with refractory pemphigus treated with high-dose cyclophosphamide.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus#1172777
- A Phase 1 QT Study in Healthy Male Subjects#895806
- The Effect of Reduced Bleomycin in Electrochemotherapy Treatment#877368
- QTc Study GSK573719+GW642444#1093478
- Pembrolizumab for Advanced NSCLC and PS 2-3#843104
Record · ID 805205
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive